Literature DB >> 1587829

DNA binding activities of c-Myc purified from eukaryotic cells.

O Papoulas1, N G Williams, R E Kingston.   

Abstract

c-Myc is a nuclear phosphoprotein which contains both a leucine zipper and a helix-loop-helix dimerization motif. These are adjacent to a basic region believed to make specific contacts with DNA upon dimerization. We report the purification of full-length c-Myc to near homogeneity from two independent eukaryotic systems: the baculovirus overexpression system using an insect cell host, and Chinese hamster ovary cells containing heat-inducible c-myc genes. The DNA binding capabilities of these preparations were characterized. Both preparations contain two distinct activities that bind specifically to sequences with a core of CACGTG. The Myc protein is solely responsible for one of these binding activities. Specific sequences that bound to c-Myc were selected from a large pool of random DNA sequence. Sequencing of individual binding sites selected by this procedure yielded a 12-base consensus, PuACCACGTGCTC, for c-Myc binding. Both protein preparations additionally demonstrated a distinct complex, containing both c-Myc and a copurifying 26-29-kDa protein, that bound to DNA with higher affinity than Myc alone. Selection of specific DNA sequences by this complex revealed a consensus binding site similar to the 12-base consensus described above. These data demonstrate that c-Myc isolated from eukaryotic cells is capable of sequence-specific DNA binding and further refine the optimal sequence for c-Myc binding. These protein preparations should prove useful in further characterizing the biochemical properties of c-Myc.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587829

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

Review 2.  In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus.

Authors:  A B Goldfine; D C Simonson; F Folli; M E Patti; C R Kahn
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

3.  Differential binding of c-Myc and Max to nucleosomal DNA.

Authors:  D S Wechsler; O Papoulas; C V Dang; R E Kingston
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

4.  Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers.

Authors:  D L Solomon; B Amati; H Land
Journal:  Nucleic Acids Res       Date:  1993-11-25       Impact factor: 16.971

5.  Cell cycle regulation of the c-Myc transcriptional activation domain.

Authors:  A Seth; S Gupta; R J Davis
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  Glycosylation of the c-Myc transactivation domain.

Authors:  T Y Chou; C V Dang; G W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.

Authors:  Leonard James; Robert N Eisenman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

8.  Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.

Authors:  Anthony Farina; Francesco Faiola; Ernest Martinez
Journal:  Protein Expr Purif       Date:  2004-04       Impact factor: 1.650

9.  Binding of myc proteins to canonical and noncanonical DNA sequences.

Authors:  T K Blackwell; J Huang; A Ma; L Kretzner; F W Alt; R N Eisenman; H Weintraub
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Base preferences for DNA binding by the bHLH-Zip protein USF: effects of MgCl2 on specificity and comparison with binding of Myc family members.

Authors:  A J Bendall; P L Molloy
Journal:  Nucleic Acids Res       Date:  1994-07-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.